Containerboard production was up 3.5 percent compared to March 2017 and up 0.5 percent year-to-date. The month-over-month average daily production compared to February 2018 was 3.5 percent higher. The containerboard operating rate was 97.4 percent or 0.7 percentage points higher than the same month last year. Production for exports was 3.3 percent lower than March 2017 and 6.7 percent lower year-to-date.
http://afandpa.org/media/news/2018/04/18/american-forest-paper-association-releases-march-2018-containerboard-report
Related Posts
Metsä Board’s CEO Mika Joukio: “In October–December, demand for paperboards was lower than expected, and our delivery volumes decreased from the previous quarter. We adjusted production to match the low demand at several of our mills. Our profitability was also burdened by the repair shut-down at Metsä Fibre’s Kemi bioproduct mill, which lasted for about a month. Our sales in October–December amounted to EUR 446 million, and our comparable operating result was EUR -3.6 million. We had a positive start to 2024, with paperboard demand picking up clearly from the previous year’s record low level. However, activity faded towards the end of the year, and our paperboard deliveries, amounting to approximately 1.5 million tonnes, remained below our capacity level. Demand is still constrained by cautious purchasing behaviour and consumption focusing more on services than products. In addition, market balance has been influenced by the strong growth in Asian paperboard capacity and increasing paperboard imports especially to Turkey, the Middle East and South America.
Virox Technologies Inc., a leading innovator of patented, sustainable disinfectant chemistries, today announces that it has finalized multi-year licensing and supply agreements with Diversey, A Solenis Company, to bring its latest patented disinfectant technology, Citr-IQTM, to the healthcare sector and others. Diversey is a leading provider of hygiene, infection prevention and cleaning products, and technology, and will add multiple disinfectant products, powered by Virox’s Citr-IQ, to its lineup of professional offerings. Under the terms of the agreements, Virox will receive undisclosed license fees and royalties for the use of the formulas covered under the patented Citr-IQ disinfectant platform, as well as manufacture products containing the Citr-IQ formulas for Diversey’s North American markets. These Citr-IQ products will be produced in Virox’s LEED® Gold Certified manufacturing facility in Oakville, Ontario, Canada. Diversey has previously licensed chemical disinfectant technology from Virox with the patented Accelerated Hydrogen Peroxide® (AHP®) platform, which Diversey fully acquired from Virox in 2019. AHP was created by Virox in 1998, and successfully transformed disinfection with a safe, effective, and sustainable patented chemistry. AHP is used across the globe in human and animal health sectors and is the active ingredient in multiple brands, including Diversey’s Oxivir® and Accel® infection prevention platforms.
Smurfit Kappa has approved transformational investment plans for its Mold plant in North Wales, that will further expand capacity at the facility, make it the largest box factory in the UK and allow the company to meet the growing demand for sustainable packaging. The investment in state-of-the-art equipment will reduce CO2 per tonne emissions by 15% at the plant. Commenting on the announcement, Smurfit Kappa UK and Ireland CEO, Eddie Fellows, said, “This investment in North Wales will increase our capability, flexibility and speed of response to deliver unrivalled, innovative packaging solutions to customers across the UK and Ireland. We are determined to meet the future needs of our customers in a sustainable way. It is vital that our investment has benefits for the local community and the environment.”